EUVIMEDEUVIMED entdecken
Open Access

α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development

Carine Jaafar iD, Purushoth Ethiraj iD, Zhijun Qiu iD, An-Ping Lin, Pedro S S M Ferrari iD, Ricardo C T Aguiar iD

Blood · 2025

DOI: 10.1182/blood.2024028069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2025. Verfasst von Carine Jaafar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Medical Oncology, Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, TX. Hauptthemen laut MEDLINE: Ketoglutaric Acids, Amino Acids, Lymphoma, B-Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIEHS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting metabolic dependencies and “starving” malignant cells have long been considered potential strategies to treat cancer. However, with rare exceptions, the implementation of these maneuvers has been fraught with limited activity and lack of specificity. Multiple cytoplasmic and mitochondrial transaminases catalyze reactions that lead to amino acid catabolism. These enzymes use α-ketoglutarate (αKG) as a nitrogen acceptor, and accumulation of the competitive inhibitor metabolite D-2-hydroxyglutarate perturbs their function. We postulated that exogenous αKG supplementation would influence the directionality of these reactions and deplete amino acids in cancer cells. Using B-cell lymphoma as a model system, we found that αKG mediates a rapid and sustained amino acid depletion, principally of aspartate and branched-chain leucine, valine, and isoleucine. The decrease in leucine levels influenced mammalian target of rapamycin complex 1 (mTORC1) subcellular movement, suppressed its activity, and associated with inhibition of B-cell lymphoma growth in vitro and in vivo. Increasing import of aspartate or leucine levels in the lymphoma cells, genetically forcing mTORC1 lysosomal localization or blocking leucine catabolism through branched-chain amino acid transaminase 2 deletion, all blunted the antilymphoma effects of αKG. In addition, long-term dietary supplementation of αKG, a toxicity-free strategy, significantly hindered lymphoma development in Eμ-Myc mice, in association with amino acid perturbation and impaired energy generation. We posit that αKG supplementation, which has been shown to improve health and life span in mice, also encodes marked anticancer properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ketoglutaric AcidsAmino AcidsLymphoma, B-CellAnimalsMiceHumansCell Line, TumorMechanistic Target of Rapamycin Complex 1Cell ProliferationTransaminases

Substanzen

Ketoglutaric AcidsAmino AcidsMechanistic Target of Rapamycin Complex 1Transaminases

Autor:innen und Institutionen

  • Division of Hematology and Medical Oncology, Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, TX.
  • South Texas Veterans Health Care System, Audie Murphy Memorial Veterans Hospital, San Antonio, TX.

ORCID-Profile: Carine Jaafar, Purushoth Ethiraj, Zhijun Qiu, Pedro S S M Ferrari, Ricardo C T Aguiar

Förderung

  • BLRD VA
  • NIEHS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Jaafar, C., Ethiraj, P., Qiu, Z., Lin, A. P., Ferrari, P. S. S. M., & Aguiar, R. C. T. (2025). α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development. Blood. https://doi.org/10.1182/blood.2024028069

Vancouver

Jaafar C, Ethiraj P, Qiu Z, Lin AP, Ferrari PSSM, Aguiar RCT. α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development. Blood. 2025. doi:10.1182/blood.2024028069

BibTeX
@article{Jaafar2025,
  author = {Jaafar, Carine and Ethiraj, Purushoth and Qiu, Zhijun and Lin, An-Ping and Ferrari, Pedro S S M and Aguiar, Ricardo C T},
  title = {α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development},
  journal = {Blood},
  year = {2025},
  doi = {10.1182/blood.2024028069}
}
Kostenlos starten →